Inflammatory biomarkers may predict response to phosphodiesterase type 5 inhibitor treatment in patients with erectile dysfunction.

Metin Kilic Anil Erkan Salim Zengin Gokce Dundar Caglar Boyaci

Published in: Investigative and clinical urology (2023)

This study showed that only MHR as an inflammatory biomarker was an independent predictor for response to PDE5i in the treatment of ED. Also, several factors were predictive of treatment failure.

Keyphrases

emergency department
oxidative stress
replacement therapy